Literature DB >> 27670891

Exploring the Prognostic Role of Microsatellite Instability in Patients With Stage II Colorectal Cancer: A Systematic Review and Meta-Analysis.

Adriana Romiti1, Eliana Rulli2, Emanuela Pilozzi1, Chiara Gerardi3, Michela Roberto1, Lorenzo Legramandi3, Rosa Falcone1, Ilaria Pacchetti3, Paolo Marchetti1, Irene Floriani3.   

Abstract

BACKGROUND: Many studies have disclosed the prognostic effect of microsatellite instability (MSI) and/or loss of mismatch repair proteins in colorectal cancer. Nevertheless, little evidence supports their role in the decision-making of adjuvant therapy for patients with stage II disease.
MATERIALS AND METHODS: The aim of this systematic review was to evaluate the prognostic and/or predictive role of MSI status in patients with stage II colorectal cancer on disease-free survival and overall survival. MEDLINE, EMBASE, and Cochrane libraries were searched to identify eligible studies.
RESULTS: Only 2 of 389 articles identified fulfilled the eligibility criteria. In both treated and untreated patients, high-level MSI improved disease-free survival compared with low-level MSI, suggesting a prognostic role but not supporting the hypothesis of a predictive effect of MSI.
CONCLUSIONS: Further studies are needed to explore the predictive role of MSI/mismatch repair proteins, because available data do not allow definitive conclusions.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adjuvant therapy; Colorectal cancer; Mismatch repair proteins; Predictive factor; Prognostic factor

Mesh:

Substances:

Year:  2016        PMID: 27670891     DOI: 10.1016/j.clcc.2016.08.007

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN: 1533-0028            Impact factor:   4.481


  6 in total

1.  Better survival of right-sided than left-sided stage II colon cancer: a propensity scores matching analysis based on SEER database.

Authors:  Shuanhu Wang; Xinxin Xu; Jiajia Guan; Rui Huo; Mulin Liu; Congqiao Jiang; Wenbin Wang
Journal:  Turk J Gastroenterol       Date:  2020-11       Impact factor: 1.852

Review 2.  Colorectal Cancer: Why Does Side Matter?

Authors:  Claire Gallois; Simon Pernot; Aziz Zaanan; Julien Taieb
Journal:  Drugs       Date:  2018-06       Impact factor: 9.546

3.  Stromal Expression of Vimentin Predicts the Clinical Outcome of Stage II Colorectal Cancer for High-Risk Patients.

Authors:  Li-Guo Liu; Xue-Bing Yan; Ru-Ting Xie; Zhi-Ming Jin; Yi Yang
Journal:  Med Sci Monit       Date:  2017-06-14

4.  Predictive Value of Metabolic Parameters Derived From 18F-FDG PET/CT for Microsatellite Instability in Patients With Colorectal Carcinoma.

Authors:  Hao Liu; Zheng Ye; Ting Yang; Hongjun Xie; Ting Duan; Mou Li; Min Wu; Bin Song
Journal:  Front Immunol       Date:  2021-08-26       Impact factor: 7.561

Review 5.  Systems-level biomarkers identification and drug repositioning in colorectal cancer.

Authors:  Hande Beklen; Esra Yildirim; Medi Kori; Beste Turanli; Kazim Yalcin Arga
Journal:  World J Gastrointest Oncol       Date:  2021-07-15

Review 6.  Defects in MMR Genes as a Seminal Example of Personalized Medicine: From Diagnosis to Therapy.

Authors:  Arianna Dal Buono; Federica Gaiani; Laura Poliani; Carmen Correale; Luigi Laghi
Journal:  J Pers Med       Date:  2021-12-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.